Is Bloom Energy Flying Under the Radar?
Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…
Buy
60
STN Quote, Financials, Valuation and Earnings
Last price:
$111.98
Seasonality move
:
1.39%
Day range:
$111.02 - $112.05
52-week range:
$73.18 - $112.28
Dividend yield:
0.56%
P/E ratio:
46.19x
P/S ratio:
2.31x
P/B ratio:
6.02x
Volume:
131.1K
Avg. volume:
164.5K
1-year change:
29.72%
Market cap:
$12.8B
Revenue:
$5.5B
EPS (TTM):
$2.42
Analysts' Opinion
-
Consensus RatingStantec has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Stantec has an estimated downside of -- from its current price of $111.99.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $111.99.
Fair Value
-
According to the consensus of 4 analysts, Stantec has -- downside to fair value with a price target of -- per share.
STN vs. S&P 500
-
Over the past 5 trading days, Stantec has overperformed the S&P 500 by 0.82% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Stantec does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Stantec has grown year-over-year revenues for 16 quarters straight. In the most recent quarter Stantec reported revenues of $1.3B.
Earnings Growth
-
Stantec has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Stantec reported earnings per share of $0.61.
Enterprise value:
13.6B
EV / Invested capital:
--
Price / LTM sales:
2.31x
EV / EBIT:
30.89x
EV / Revenue:
2.46x
PEG ratio (5yr expected):
5.90x
EV / Free cash flow:
33.09x
Price / Operating cash flow:
31.15x
Enterprise value / EBITDA:
20.30x
Gross Profit (TTM):
$2.4B
Return On Assets:
5.54%
Net Income Margin (TTM):
5.01%
Return On Equity:
13.21%
Return On Invested Capital:
8.6%
Operating Margin:
7.95%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $4.5B | $4.9B | $5.5B | $1.3B | $1.3B | |
| Gross Profit | $1.9B | $2.1B | $2.4B | $550.5M | $586.6M | |
| Operating Income | $316.3M | $390.2M | $450.6M | $87.7M | $106.4M | |
| EBITDA | $539.9M | $615M | $668.4M | $149.5M | $159.6M | |
| Diluted EPS | $1.82 | $2.25 | $2.42 | $0.50 | $0.61 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.2B | $1.4B | $1.4B | $1.7B | $1.8B | |
| Total Assets | $3.5B | $4.2B | $4.2B | $5B | $4.8B | |
| Current Liabilities | $744.8M | $910.3M | $972M | $1.3B | $1.3B | |
| Total Liabilities | $1.9B | $2.6B | $2.4B | $2.8B | $2.7B | |
| Total Equity | $1.5B | $1.6B | $1.7B | $2.1B | $2.1B | |
| Total Debt | $554.2M | $1B | $971M | $1.1B | $995.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $256.3M | $389.6M | $478.3M | $31.7M | $70M | |
| Cash From Investing | -$96.9M | -$434.2M | -$153.8M | -$302.6M | -$15M | |
| Cash From Financing | -$229.7M | $94.4M | -$302.9M | $154.5M | -$37.4M | |
| Free Cash Flow | $192.8M | $316.1M | $410.1M | $16.5M | $58.8M | |
STN
Sector
Market Cap
$12.8B
$609.6M
Price % of 52-Week High
99.74%
81.57%
Dividend Yield
0.56%
0%
Shareholder Yield
--
2.3%
1-Year Price Total Return
29.72%
-0.51%
Beta (5-Year)
1.026
0.761
Dividend yield:
0.56%
Annualized payout:
$0.61
Payout ratio:
24.8%
Growth streak:
9 years
Technicals
8-day SMA
Buy
Level
$110.92
200-day SMA
Buy
Level
$87.94
Bollinger Bands (100)
Buy
Level
83.86 - 105.84
Chaikin Money Flow
Buy
Level
337.1K
20-day SMA
Buy
Level
$109.31
Relative Strength Index (RSI14)
Buy
Level
68.21
ADX Line
Buy
Level
20.21
Williams %R
Sell
Level
-5.8
50-day SMA
Buy
Level
$104.99
MACD (12, 26)
Buy
Level
30.91
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Neutral
Level
269.6K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.7137)
Buy
CA Score
(Annual)
Level (0.0716)
Buy
Beneish M-Score
(Annual)
Level (-2.4807)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.1439)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. It offers services through the following business operating units; Environmental Services, Infrastructure, Water, Buildings, and Energy & Resources. Maximum revenue is derived from its Infrastructure business unit, which is engaged in evaluating, planning, and designing infrastructure solutions for transportation, community development, and urban spaces. The company's reportable segments are the United States, which derives maximum revenue, Canada, and Global. These segments provide consulting in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics services in the area of infrastructure and facilities.
Stock Forecast FAQ
In the current month, STN has received 3 Buy ratings 1 Hold ratings, and 0 Sell ratings. The STN average analyst price target in the past 3 months is --.
-
Where Will Stantec Stock Be In 1 Year?
According to analysts, the consensus estimate is that Stantec share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Stantec?
Analysts are divided on their view about Stantec share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Stantec is a Sell and believe this share price will rise from its current level to --.
-
What Is Stantec's Price Target?
The price target for Stantec over the next 1-year time period is forecast to be -- according to 4 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is STN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Stantec is a Buy. 3 of 4 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of STN?
You can purchase shares of Stantec via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Stantec shares.
-
What Is The Stantec Share Price Today?
Stantec was last trading at $111.98 per share. This represents the most recent stock quote for Stantec. Yesterday, Stantec closed at $111.99 per share.
-
How To Buy Stantec Stock Online?
In order to purchase Stantec stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
61
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
55
TLN alert for Jul 19
Talen Energy [TLN] is up 24.44% over the past day.
Sell
48
CRSP alert for Jul 19
CRISPR Therapeutics AG [CRSP] is up 18.22% over the past day.
Buy
83
SOC alert for Jul 19
Sable Offshore [SOC] is up 11.86% over the past day.
